Pennington Biomedical Research Center today announced it is conducting its first vaccination trial, participating in testing the safety and effectiveness of Moderna’s COVID-19 vaccine for children under 12 in a phase three clinical trial.
Already an INSIDER? Sign in.
We are glad you enjoy reading Business Report.
Continue reading this story and get ACCESS to all our content from any device with a subscription now.
- Get access to more than a decade of story archives.
- Get access to our searchable data center of TOP LISTS.
- Get exclusive content only available to INSIDERS.
